DENVER, Oct. 16 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. (OTC Bulletin Board: GLOB), an international e-Health, medical information technology company, today announced that it will report its third quarter results on Tuesday, October 30, 2007, before the market open. The Company will host a conference call at 4:30 p.m. EDT on the same day.
Conference Call Details:
Dr. Mick Ruxin, Chief Executive Officer, Tom Marcinek, President and Chief Operating Office, and Darren Craig, Manager of Finance, will discuss the third quarter results and will be available to answer questions. The conference call will be held on Tuesday, October 30, 2007, at 4:30 p.m. EST.
Interested parties are welcome to call the telephone numbers listed below, five minutes prior to the start of the conference call. Callers within the US should call: 1-866 789-9224. Callers that are outside of the US should call: 1-706 679-9621. Callers should reference "Global Med Technologies Earnings Conference Call" to the conference call operator, and the conference call ID no. is: 20490215.
An automated replay of the conference call will be available from October 30th at 5:30 p.m. (EDT) until November 1st at 11:59 p.m. (EDT). To access the replay, please call 1-800 642-1687 if within the US. Callers that are located outside of the US should call: 1-706 645-9291 and enter Global Med's access code of 20490215.
The replay of the conference call will be available from November 1st onward at Global Med's website at http://www.globalmedtech.com.
About Global Med Technologies, Inc.
Global Med Technologies(R), Inc. is an international e-Health medical information technology company providing information management software products and services to the healthcare industry. Its Wyndgate Technologies(R) division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Each year, Wyndgate's products and services manage more than eight million blood components, representing over 27% of the U.S. blood supply. Wyndgate's products are also being used in Canada and sub-Saharan Africa, and are being implemented in the Caribbean. Together, the Donor Doc(TM) interactive donor health history questionnaire, SafeTrace(R) donor management system, and the SafeTrace Tx(R) advanced transfusion management system, recently patented, provide Vein-to-Vein(R) tracking from donor collection to patient transfusion.
This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release.
|SOURCE Global Med Technologies, Inc.|
Copyright©2007 PR Newswire.
All rights reserved